eptifibatide

Generic: eptifibatide

Labeler: hainan shuangcheng pharmaceuticals co., ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eptifibatide
Generic Name eptifibatide
Labeler hainan shuangcheng pharmaceuticals co., ltd.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

eptifibatide 2 mg/mL

Manufacturer
Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Identifiers & Regulatory

Product NDC 52958-402
Product ID 52958-402_6f3dec26-ea9b-4e6e-8e5b-0fa6fb430598
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213081
Listing Expiration 2026-12-31
Marketing Start 2021-09-07

Pharmacologic Class

Established (EPC)
platelet aggregation inhibitor [epc]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52958402
Hyphenated Format 52958-402

Supplemental Identifiers

RxCUI
200349 1736470
UPC
0352958402017
UNII
NA8320J834
NUI
N0000008832 N0000175578

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eptifibatide (source: ndc)
Generic Name eptifibatide (source: ndc)
Application Number ANDA213081 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (52958-402-01) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

eptifibatide (2 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "6f3dec26-ea9b-4e6e-8e5b-0fa6fb430598", "openfda": {"nui": ["N0000008832", "N0000175578"], "upc": ["0352958402017"], "unii": ["NA8320J834"], "rxcui": ["200349", "1736470"], "spl_set_id": ["c488f1af-a82c-4360-8886-79520635561a"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Platelet Aggregation Inhibitor [EPC]"], "manufacturer_name": ["Hainan Shuangcheng Pharmaceuticals Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (52958-402-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "52958-402-01", "marketing_start_date": "20210907"}], "brand_name": "Eptifibatide", "product_id": "52958-402_6f3dec26-ea9b-4e6e-8e5b-0fa6fb430598", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Platelet Aggregation [PE]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "52958-402", "generic_name": "Eptifibatide", "labeler_name": "Hainan Shuangcheng Pharmaceuticals Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eptifibatide", "active_ingredients": [{"name": "EPTIFIBATIDE", "strength": "2 mg/mL"}], "application_number": "ANDA213081", "marketing_category": "ANDA", "marketing_start_date": "20210907", "listing_expiration_date": "20261231"}